🇺🇸 FDA

Company profile · Sponsor

STEBA

STEBA Biotech S.A

E635E8A · EMA biotech EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

STEBA (E635E8A) is a biotech company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E635E8A
Exchange EMA
Company type biotech
Headquarters EU

Pipeline (1)

Search pipeline →

  1. TOOKAD 183 mg powder for solution for injection, PADELIPORFIN

    STEBA

    Low Grade Upper Tract Urothelial Cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is STEBA?

STEBA (E635E8A) is a biotech company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does STEBA sponsor?

We track 1 ClinicalTrials.gov-linked program for STEBA, including TOOKAD 183 mg powder for solution for injection, PADELIPORFIN. Open each program for phase, modality, NCT IDs, and indication details.

Where does STEBA company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.